NCT05448560Active, not recruiting
A Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship
BRidging Information Divides and Gaps to Ensure Survivorship: the BRIDGES Randomized Controlled Trial of a Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship
Source: ClinicalTrials.gov · Last updated 26 Oct 2026
Brief summary (registry, in English)
More than 80% of childhood cancer survivors develop serious or life-threatening late effects after cancer therapy, but \<20% receive recommended survivorship care offered at cancer center survivorship clinics. In a shared care model, the investigators propose to investigate an innovative multi-level intervention consisting of: 1) patient survivorship education via telehealth with the cancer center, 2) ongoing patient-tailored education program within the electronic health record patient portal, 3) a structured interactive phone communication between the cancer center and the primary care clinic, and 4) an in-person visit with the primary care clinic for survivorship care with the goal of achieving high rates of adherence to recommended surveillance for late effects, as well as improving patient and physician knowledge and self-efficacy. If this scalable intervention demonstrates patient completion of recommended care comparable to cancer center survivorship clinics, this innovative study has the enormous potential to deliver recommended care to a larger proportion of childhood cancer survivors and reduce survivorship care disparities, while engaging p to integrate survivorship care as part of overall, lifelong health maintenance.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 240 (estimated)
- First submitted
- 16 Jun 2022
- Start date
- 1 Jan 2023
- Primary completion date
- 28 Feb 2027
- Lead sponsor
- Georgetown University
- Diseases
- Childhood cancers
- NCT number
- NCT05448560
What you commit to
- Study type: Interventional
- Planned participants: 240
- From 1 Jan 2023 to the primary completion date, 28 Feb 2027
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Active medical problems severe enough to not be eligible for receiving survivorship care with primary care provider at the time of recruitment
Who the study is looking for
- Diagnosed with any cancer at age \<21 years
- Treated with chemotherapy and/or radiation
- 2.0-4.0 years status post-completion of all cancer-related therapy
- Cancer-free with a life expectancy of ≥2 years
- English- or Spanish-speaking (also applies to parent/guardian if patient age \<18 years)
- No previous attendance at a specialty survivorship clinic
- Followed at one of the 4 participating sites: Hackensack, University of North Carolina- Chapel Hill (UNC), University of Colorado Denver (CU), Miller's Children's and Women's Hospital Long Beach (MCWH)
Age in the registry: 2 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of North Carolina Children's Hospital Coordinator of this site? Confirm its status | Chapel Hill | United States | Unknown status |
| Children's Hospital Colorado Coordinator of this site? Confirm its status | Denver | United States | Unknown status |
| Hackensack University Medical Center Coordinator of this site? Confirm its status | Hackensack | United States | Unknown status |
| MemorialCare Miller Children's & Women's Hospital Long Beach Coordinator of this site? Confirm its status | Long Beach | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.